Speranza Therapeutics announces value-based program for opioid detox facilities program vows to reduce costly facility against Medical Advice (AMA) leave rates
August 4, 2021
August 4, 2021
August 3, 2021
July 27, 2021
July 27, 2021
June 10, 2021
June 10, 2021
May 27, 2021
March 25, 2021
March 22, 2021
March 10, 2026
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision Ci...
February 25, 2026
Epigenica today announces the launch of EpiFinder™ cNUC, a truly unique product for liquid biopsies that significantly expands the capabilities of epi...
February 23, 2026
Inceptua Group, a leading global provider of clinical trial services and supplies, and early access programs, announces the appointment of Kurt J. Hil...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225